Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim PharmafiledCriticalBoehringer Ingelheim Pharma
Priority to UY26346ApriorityCriticalpatent/UY26346A1/en
Publication of UY26346A1publicationCriticalpatent/UY26346A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a derivados de bencimidazol sustituidos de la fórmula general (I) en donde los radicales R1, R2, R3 y R4 pueden tener los significados mencionados en las reivindicaciones y en la memoria descriptiva, a un procedimiento para su preparación, así como al empleo de derivados de bencimidazol sustituidos como medicamentos, en particular como medicamentos con efecto inhibidor de triptasa.The invention relates to substituted benzimidazole derivatives of the general formula (I) wherein the radicals R1, R2, R3 and R4 can have the meanings mentioned in the claims and in the specification, to a process for their preparation, as well as to the use of substituted benzimidazole derivatives as drugs, in particular as drugs with a tryptase inhibiting effect.
UY26346A2000-09-202000-09-20
SUBSTITUTED BENCIMIDAZOLE DERIVATIVES, PREPARATION PROCEDURE AND THEIR USE AS MEDICINES.
UY26346A1
(en)